Güner Hayri Özsan
Dokuz Eylül University
43Publications
5H-index
94Citations
Publications 43
Newest
Published on Nov 1, 2018in British Journal of Haematology 5.13
Jan Walewski31
Estimated H-index: 31
(Curie Institute),
Andrzej Hellmann22
Estimated H-index: 22
(Gdańsk Medical University)
+ 12 AuthorsEwa Paszkiewicz-Kozik5
Estimated H-index: 5
(Curie Institute)
1 Citations Source Cite
Published on Sep 30, 2017in Cukurova Medical Journal
Nurhilal Buyukkurt2
Estimated H-index: 2
,
Güner Hayri Özsan5
Estimated H-index: 5
+ 6 AuthorsBulent Undar11
Estimated H-index: 11
Amac: Bircok faktor hematopoetik kok hucre (HKH) engraftmanini etkiler. Bu calismada hematolojik kanseri olan hastalarda kemik iligindeki myelofibrozis ve anjiogenezisin engraftman uzerine etkisi arastirilmistir. Gerec ve Yontem: Otolog kok hucre nakli yapilan 34 hasta (20 erkek, 14 kadin) verileri degerlendirildi. Nakilden onceki son kemik iligindeki fibrozis 0-3 arasinda derecelendirildi, anjiogenezis stereolojik metod ile olculdu. Hastalar anjiogenezis parametrelerinin yogunluguna gore de iki...
Source Cite
Published on Apr 3, 2015in Chemotherapy 2.00
Inci Alacacioglu7
Estimated H-index: 7
,
Serife Solmaz Medeni1
Estimated H-index: 1
+ 9 AuthorsMehmet Ali Özcan13
Estimated H-index: 13
Multiple induction regimens have been developed for adult patients with acute lymphoblastic leukemia (ALL). However, there have been no prospective randomized trials that directly compare these regimens. In this study, we wanted to evaluate the outcome of 50 adult ALL patients treated with BFM (i.e. Berlin-Frankfurt-Munster, n = 20) and hyper-CVAD (n = 30) protocols between March 2006 and October 2012. The median age was 25 years in the BFM group and 30.5 years in the hyper-CVAD group with a mal...
4 Citations Source Cite
Published on Oct 1, 2015in Clinical and Applied Thrombosis-Hemostasis 1.85
Abdullah Katgi4
Estimated H-index: 4
(Dokuz Eylül University),
Omur Gokmen Sevindik3
Estimated H-index: 3
(Dokuz Eylül University)
+ 8 AuthorsYusuf Baran22
Estimated H-index: 22
(İzmir Institute of Technology)
Background:There have been concerns about the possible prothrombotic effects of nilotinib, especially in patients having cardiovascular risk factors. The potential mechanism behind the increased risk of thromboembolic events is still not clear.Objectives:In this study, we aimed to evaluate possible harmful effects of nilotinib on endothelial cells. To this aim, we examined proliferative capacity and secretory functions of healthy human carotid artery endothelial cells (HCtAECs) in response to ni...
5 Citations Source Cite
Published on Sep 1, 2015in Clinical Lymphoma, Myeloma & Leukemia 2.31
Omur Gokmen Sevindik3
Estimated H-index: 3
(Dokuz Eylül University),
Inci Alacacioglu7
Estimated H-index: 7
(Dokuz Eylül University)
+ 8 AuthorsGüner Hayri Özsan5
Estimated H-index: 5
(Dokuz Eylül University)
e202 Methods: We present a series of 4 patients diagnosed with plasma cell leukemia (PCL) between 2009 and 2014. The LCP was diagnosed in these cytomorphology and by study of peripheral blood cytometry. 25% had LCP Primary BJ Lambda MM and 75% LPC Secondary. The therapeutic use in our patients was diverse and personalized; patients with Primary LPC receiving schemes with Bortezomib (25%) plus autologous stem cell transplantation and patients with Secundary LPC Dexamethasone alone (75%). Results:...
Source Cite
Published on Jan 1, 2015in Case reports in hematology
Omur Gokmen Sevindik3
Estimated H-index: 3
,
Inci Alacacioglu7
Estimated H-index: 7
+ 7 AuthorsGüner Hayri Özsan5
Estimated H-index: 5
Transplantation-associated thrombotic microangiopathy (TA-TMA) is a challenge after allogeneic hematopoietic progenitor cell transplantation, considering the diagnostic uncertainties and lack of established treatment. We report a 43-year-old male patient who was diagnosed as TA-TMA after allogeneic progenitor cell transplantation for a progressive ALK negative anaplastic large cell lymphoma and responded to eculizumab with dramatically improving neurological status and renal function. Rapid neur...
5 Citations Source Cite
Published on Jun 1, 2015in Clinical Lymphoma, Myeloma & Leukemia 2.31
Omur Gokmen Sevindik3
Estimated H-index: 3
(Dokuz Eylül University),
Sinan Mersin1
Estimated H-index: 1
(Dokuz Eylül University)
+ 9 AuthorsFatih Demirkan11
Estimated H-index: 11
(Dokuz Eylül University)
Abstract Introduction Essential thrombocythemia (ET) is the most common of the myeloproliferative neoplasms. For better predicting the occurrence of thrombotic events, an International Prognostic Score of Thrombosis for ET (IPSET-Thrombosis) was recently developed. We aimed to investigate the validity of IPSET-Thrombosis in a Turkish patient cohort and to compare the efficacy of IPSET-Thrombosis and conventional risk scoring systems in predicting thrombosis-free survival. Patients and Methods We...
1 Citations Source Cite
Published on Sep 2, 2015in Leukemia & Lymphoma 2.64
Omur Gokmen Sevindik3
Estimated H-index: 3
(Dokuz Eylül University),
Zeynep Gulsum Guc2
Estimated H-index: 2
(Dokuz Eylül University)
+ 9 AuthorsFatih Demirkan11
Estimated H-index: 11
(Dokuz Eylül University)
The serum albumin (SA) level has been reported to be an independent prognostic biomarker that may serve as a surrogate representative of disease biology in patients diagnosed with myelodysplastic syndrome (MDS). However, its prognostic ability has not been tested in a model adjusting for comorbidities. We analyzed 200 patients who were diagnosed as having de novo MDS. Median overall survival (OS) of all patients was 25 months and median leukemia-free survival (LFS) was 24 months. Median OS accor...
2 Citations Source Cite
12345